This project is focused on two intestinal epthelial cells that are specialized for uptake of luminal macromolecules--the absorptive cell of neonatalileum, and the M cell of Peyers's patch. Although they differ dramatically in structure and function, both cell types provide valuable models for study of epithelial membrane traffic, intracellular sorting, and transepithelial transport. In neonatal ileum, tracer proteins and immunocytochemistry will be used to detect sorting of physiologic and foreign adsorptive ligands and receptors at luminal cell surfaces and in apical endosomal tubules, and selective transepithelial transport. Subcellular fractions enriched in tubules will be analysed biochemically and used to raise organelle-specific antibodies, that in turn will serve as membrane markers. The independent recycling of apical and basolateral endocytic membranes and the convergence of these polarized pathways in the central lysosomal system will be demonstrated using tracer ligands and lysosome-specific antibodies. Transport of antigens across rat and rabbit M cells will be assessed in quantitative studies using ultrastructural and fluorescent tracers and radiolabeled probes. Relative efficiencies of transport of soluble vs. adherant molecules and particles, and specific types of adherent monomeric or polymeric molecules will be systematically compared. M cell membrane domains and the transepithelial transport pathway will be further explored using domain-specific antibodies and probes specific for acidic compartments, along with tracer proteins. New information on membrane traffic and selective and nonselective protein transport in these cells will clarify their roles in epithelial barrier function and mucosal immunity.

Agency
National Institute of Health (NIH)
Institute
Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)
Type
Method to Extend Research in Time (MERIT) Award (R37)
Project #
5R37HD017557-09
Application #
3485123
Study Section
General Medicine A Subcommittee 2 (GMA)
Project Start
1983-07-01
Project End
1991-06-30
Budget Start
1990-07-01
Budget End
1991-06-30
Support Year
9
Fiscal Year
1990
Total Cost
Indirect Cost
Name
Children's Hospital Boston
Department
Type
DUNS #
076593722
City
Boston
State
MA
Country
United States
Zip Code
02115
Chabot, Sophie M; Shawi, May; Eaves-Pyles, Tonyia et al. (2008) Effects of flagellin on the functions of follicle-associated epithelium. J Infect Dis 198:907-10
Neutra, Marian R; Kozlowski, Pamela A (2006) Mucosal vaccines: the promise and the challenge. Nat Rev Immunol 6:148-58
Chabot, Sophie; Wagner, Jessica S; Farrant, Stephanie et al. (2006) TLRs regulate the gatekeeping functions of the intestinal follicle-associated epithelium. J Immunol 176:4275-83
Hutchings, Amy B; Helander, Anna; Silvey, Katherine J et al. (2004) Secretory immunoglobulin A antibodies against the sigma1 outer capsid protein of reovirus type 1 Lang prevent infection of mouse Peyer's patches. J Virol 78:947-57
Helander, Anna; Silvey, Katherine J; Mantis, Nicholas J et al. (2003) The viral sigma1 protein and glycoconjugates containing alpha2-3-linked sialic acid are involved in type 1 reovirus adherence to M cell apical surfaces. J Virol 77:7964-77
Shreedhar, Vijay K; Kelsall, Brian L; Neutra, Marian R (2003) Cholera toxin induces migration of dendritic cells from the subepithelial dome region to T- and B-cell areas of Peyer's patches. Infect Immun 71:504-9
Didierlaurent, Arnaud; Sirard, Jean-Claude; Kraehenbuhl, Jean-Pierre et al. (2002) How the gut senses its content. Cell Microbiol 4:61-72
Mantis, Nicholas J; Cheung, Marsha C; Chintalacharuvu, Koteswara R et al. (2002) Selective adherence of IgA to murine Peyer's patch M cells: evidence for a novel IgA receptor. J Immunol 169:1844-51
Silvey, K J; Hutchings, A B; Vajdy, M et al. (2001) Role of immunoglobulin A in protection against reovirus entry into Murine Peyer's patches. J Virol 75:10870-9
Mantis, N J; Kozlowski, P A; Mielcarz, D W et al. (2001) Immunization of mice with recombinant gp41 in a systemic prime/mucosal boost protocol induces HIV-1-specific serum IgG and secretory IgA antibodies. Vaccine 19:3990-4001

Showing the most recent 10 out of 59 publications